Auranofin Has Advantages over First-Line Drugs in the Treatment of Severe <i>Streptococcus suis</i> Infections

Auranofin Has Advantages over First-Line Drugs in the Treatment of Severe <i>Streptococcus suis</i> Infections

Streptococcal toxic shock-like syndrome (STSLS) likely occurs when an individual is infected with the <i>Streptococcus suis</i> (<i>S. suis</i>) epidemic strain and is characterized by a cytokine storm, multiple organ dysfunction syndrome (MODS) and a high incidence of mortal...

Full description

Bibliographic Details
Main Authors: Hao Lu, Wenjia Lu, Yongwei Zhu, Chenchen Wang, Liming Shi, Xiaodan Li, Zhaoyuan Wu, Gaoyan Wang, Wenqi Dong, Chen Tan, Manli Liu
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Antibiotics
Subjects:
STSLS
<i>Streptococcus suis</i>
auranofin
molecular docking
Online Access:https://www.mdpi.com/2079-6382/10/1/26

Similar Items

Similar Items